Drugs / Jin Youli
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04518800 | Aug 2020 → Aug 2021 | malignant pancreatic neoplasm | Chinese PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jin Youli | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04518800 ↗ |
| Known as | PEG-rhG-CSF | “Jin Youli(PEG-rhG-CSF)” NCT04518800 ↗ |